China Baoan Group Co., Ltd.

Shenzhen Stock Exchange 000009.SZ

China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 8.29%

China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) is 8.29% for the year ending December 31, 2023, a -29.28% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 11.72%, a -2.40% change year over year.
China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 12.01%, a 21.95% change year over year.
China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 9.85%, a 0.27% change year over year.
China Baoan Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 9.82%, a 9.59% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shenzhen Stock Exchange: 000009.SZ

China Baoan Group Co., Ltd.

CEO	Mr. Zhengli Chen
IPO Date	June 25, 1991
Location	China
Headquarters	Bao'an Plaza
Employees	16,595
Sector	Materials
Industries Lithium Chemicals & Advanced Materials Cleaning Supplies Composite Materials Defense & Military Hardware & Electronics Personal Care Plastics

Description

China Baoan Group Co., Ltd. engages in the research, development, production, and sale of lithium-ion battery anode and cathode materials. It also manufactures and sells precision metal parts, electric vehicles, AC and DC charging connectors, motors and controllers, automobile exhaust gas purifiers, and civilian air purification products, as well as military products that include military on-board communication equipment, military simulation training systems, beidou technology, and radar electronic countermeasure technology products. In addition, the company engages in the manufacture, retail, and wholesale of pharmaceuticals; provision of biological pesticides and fertilizers, and hospital diagnosis and treatment services; and planting, research, development, production, and sale of neem. Further, it is involved in real estate development; investment and financing; mining; and mineral resources selection activities. The company was founded in 1983 and is based in Shenzhen, China.

Key trends

Past 5 years